10-Q: Quarterly report
8-K: Telesis Bio Reports First Quarter 2024 Financial Results
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Witney Frank
4: Statement of changes in beneficial ownership of securities-Director TUMOLO ANNETTE
4: Statement of changes in beneficial ownership of securities-Director TSINGOS CHRISTINE A
4: Statement of changes in beneficial ownership of securities-Director NACHTSHEIM JAMI K
4: Statement of changes in beneficial ownership of securities-Director Herrema Gregory J.
ARS: Annual Report to Security Holders
4: Statement of changes in beneficial ownership of securities-Officer Esser Eric Eugene
DEF 14A: Definitive information statements
8-K: Current report
TELESIS BIO | PRE 14A: Preliminary proxy statements relating to merger or acquisition
TELESIS BIO | 8-K: Current report
TELESIS BIO | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
TELESIS BIO | 10-K: Annual report
TELESIS BIO | 8-K: Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
TELESIS BIO | 4: Statement of changes in beneficial ownership of securities-Officer Nelson Todd Robert
TELESIS BIO | 4: Statement of changes in beneficial ownership of securities-Officer Esser Eric Eugene
TELESIS BIO | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Daniel Glenn
No Data